Views from the Top: Clinical Trials Readiness: Increasing Speed, Equity, and Impact

The COVID pandemic revealed significant gaps in our US clinical trials infrastructure.  In the early days of the outbreak, we saw a fragmented research response, with many studies too small to generate actionable evidence.  How can we do larger, coordinated trials more rapidly, and make them simpler for practitioners and patients?  How do we best use decentralized trial designs and digital health technologies?  How can we push out protocols to a broader range of sites and communities, increase equity, and gather consistent data elements for rapid research access?  In this session, we’ll explore the role that 21^st Century health IT infrastructure can play in supporting these goals, including the use of HL7 FHIR APIs, USCDI/USCDI+, and the potential for leveraging TEFCA in the future.